2024 Q1 Form 10-Q Financial Statement

#000143774924004170 Filed on February 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $453.7K $475.6K
YoY Change -39.38% -35.27%
Cost Of Revenue $0.00 $780.00
YoY Change -94.27%
Gross Profit $453.7K $474.8K
YoY Change -39.38% -34.15%
Gross Profit Margin 100.0% 99.84%
Selling, General & Admin $498.6K $515.7K
YoY Change 4.04% 0.49%
% of Gross Profit 109.91% 108.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $115.6K $115.6K
YoY Change 1.99% 2.74%
% of Gross Profit 25.47% 24.34%
Operating Expenses $498.6K $515.7K
YoY Change 4.03% 0.49%
Operating Profit -$44.93K -$40.89K
YoY Change -116.69% -119.67%
Interest Expense -$121.2K -$131.1K
YoY Change -33.63% -29.19%
% of Operating Profit
Other Income/Expense, Net -$121.2K -$131.1K
YoY Change -33.62% -29.2%
Pretax Income -$166.1K -$172.0K
YoY Change -291.75% -856.04%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$166.1K -$172.0K
YoY Change -291.74% -856.21%
Net Earnings / Revenue -36.61% -36.16%
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 24.39M 24.39M
Diluted Shares Outstanding 24.39M 24.39M

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $513.4K $807.6K
YoY Change -59.02% -36.57%
Cash & Equivalents $513.4K $807.6K
Short-Term Investments
Other Short-Term Assets $50.13K $32.77K
YoY Change 15.77% 146.39%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.267M $1.283M
YoY Change -20.06% -17.77%
LONG-TERM ASSETS
Property, Plant & Equipment $13.22M $13.35M
YoY Change -3.54% -2.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.52M $13.68M
YoY Change -1.32% 0.27%
TOTAL ASSETS
Total Short-Term Assets $1.267M $1.283M
Total Long-Term Assets $13.52M $13.68M
Total Assets $14.79M $14.96M
YoY Change -3.26% -1.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $73.20K $86.78K
YoY Change -14.07% -33.16%
Accrued Expenses $59.18K $54.49K
YoY Change 10.04% -6.05%
Deferred Revenue
YoY Change
Short-Term Debt $5.082M $5.082M
YoY Change 14.58% 15.85%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.221M $5.223M
YoY Change 13.92% 14.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $4.198M $4.201M
YoY Change -0.3% -0.3%
Total Long-Term Liabilities $4.198M $4.201M
YoY Change -12.4% -12.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.221M $5.223M
Total Long-Term Liabilities $4.198M $4.201M
Total Liabilities $9.419M $9.424M
YoY Change 0.47% 0.52%
SHAREHOLDERS EQUITY
Retained Earnings -$20.19M -$20.03M
YoY Change 2.76% 1.47%
Common Stock $2.439K $2.439K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.369M $5.535M
YoY Change
Total Liabilities & Shareholders Equity $14.79M $14.96M
YoY Change -3.26% -1.59%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$166.1K -$172.0K
YoY Change -291.74% -856.21%
Depreciation, Depletion And Amortization $115.6K $115.6K
YoY Change 1.99% 2.74%
Cash From Operating Activities -$314.5K -$337.2K
YoY Change -294.75% -403.09%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $20.28K $9.850K
YoY Change 100.4% -15.09%
Cash From Investing Activities $20.28K $9.845K
YoY Change -111.15% -133.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -314.5K -$337.2K
Cash From Investing Activities 20.28K $9.845K
Cash From Financing Activities 0.000 $0.00
Net Change In Cash -294.2K -$327.4K
YoY Change 1338.48% 382.82%
FREE CASH FLOW
Cash From Operating Activities -$314.5K -$337.2K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$314.5K -$337.2K
YoY Change 928.62% -577.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
13615 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
807607 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1283433 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5223089 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4204389 usd
CY2023Q3 us-gaap Liabilities
Liabilities
9447537 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24391961
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2439 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25558362 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20025443 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5535358 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14959632 usd
CY2023Q4 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
475629 usd
CY2022Q4 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
734766 usd
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001508348
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1135006 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q4 acan Tenant Receivable Current
TenantReceivableCurrent
379064 usd
CY2023Q3 acan Tenant Receivable Current
TenantReceivableCurrent
103450 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22797 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23415 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
63998 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
62116 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1333954 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
326157 usd
CY2023Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
337884 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6691391 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6708843 usd
CY2023Q4 us-gaap Assets
Assets
14959632 usd
CY2023Q3 us-gaap Assets
Assets
15154894 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
86775 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
87247 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
42042 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
40686 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
180 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6365 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12446 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12204 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4500000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
4500000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5243148 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4201185 usd
CY2023Q4 us-gaap Liabilities
Liabilities
9424274 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24391961
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24391961
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2439 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25558362 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19853444 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5707357 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15154894 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
403610 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
391306 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
515742 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
513237 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-40893 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
207914 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
7951 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
1663 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-131106 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-185169 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-171999 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5802112 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5824857 usd
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
5707357
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-171999 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
115562 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112481 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17452 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17228 usd
CY2023Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
48706 usd
CY2023Q4 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
275614 usd
CY2022Q4 acan Increase Decrease In Tenant Receivable
IncreaseDecreaseInTenantReceivable
-8912 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-618 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-59433 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-472 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-63328 usd
CY2023Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2962 usd
CY2022Q4 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2739 usd
CY2023Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1356 usd
CY2022Q4 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-7476 usd
CY2023Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-6185 usd
CY2022Q4 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2192 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-337244 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111270 usd
CY2023Q4 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
-0 usd
CY2022Q4 us-gaap Payments For Construction In Process
PaymentsForConstructionInProcess
40684 usd
CY2023Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
9845 usd
CY2022Q4 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
11604 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9845 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29080 usd
CY2023Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-327399 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-67810 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1144973 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1351094 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
817574 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1283284 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
137701 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
145602 usd
CY2023Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
807607 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1135006 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
9967 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
817574 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1144973 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8206888 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8206888 usd
CY2023Q4 us-gaap Depreciation
Depreciation
115562 usd
CY2022Q4 us-gaap Depreciation
Depreciation
112481 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20025443 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19853444 usd
CY2023Q4 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.12 pure
CY2023Q3 acan Note Receivable Interest Rate
NoteReceivableInterestRate
0.12 pure
CY2023Q4 acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
8898 usd
CY2023Q4 acan Note Receivable Periodic Payment
NoteReceivablePeriodicPayment
8898 usd
CY2023Q4 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
390155 usd
CY2023Q3 acan Notes And Other Receivables Net
NotesAndOtherReceivablesNet
400000 usd
CY2023Q4 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
-63998 usd
CY2023Q3 acan Notes And Other Receivables Net Current
NotesAndOtherReceivablesNetCurrent
-62116 usd
CY2023Q4 us-gaap Notes Receivable Net
NotesReceivableNet
326157 usd
CY2023Q3 us-gaap Notes Receivable Net
NotesReceivableNet
337884 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-171999 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
22745 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24391961
CY2023Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24391961
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6980957 usd
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4256869 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6691391 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12446 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4201185 usd
CY2023Q4 acan Operating Cash Flows From Operating Leases
OperatingCashFlowsFromOperatingLeases
85375 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P42Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
256125 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
341500 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
341500 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
341500 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
341500 usd
CY2023Q4 acan Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
12977000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14599125 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10385494 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4213631 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12446 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4201185 usd
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
120344 usd
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
120344 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y4M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.94
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1700000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.94
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2148000
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.33
CY2023 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y1M17D
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2148000
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.33
CY2023Q4 acan Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P0Y10M17D
CY2023Q4 acan Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
2148000
CY2023Q4 acan Class Of Warrant Or Right Exercisable Exercise Price
ClassOfWarrantOrRightExercisableExercisePrice
1.33
CY2023Q4 acan Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P0Y10M17D

Files In Submission

Name View Source Status
0001437749-24-004170-index-headers.html Edgar Link pending
0001437749-24-004170-index.html Edgar Link pending
0001437749-24-004170.txt Edgar Link pending
0001437749-24-004170-xbrl.zip Edgar Link pending
acan-20231231.xsd Edgar Link pending
acan20231231_10q.htm Edgar Link pending
ex_623640.htm Edgar Link pending
ex_623641.htm Edgar Link pending
ex_623642.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
acan-20231231_def.xml Edgar Link unprocessable
acan-20231231_lab.xml Edgar Link unprocessable
acan-20231231_pre.xml Edgar Link unprocessable
acan20231231_10q_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
acan-20231231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable